Mativ

US · MATV #3563 by market cap

11.60 -0.26 -2.19%

Live - 5344 symbols - heartbeat 106s ago · 2026-10-09 19:30

✦ Quant Financial Health how this is computed

Weak

Altman Z-Score is 1.37, below the 1.8 "distress zone" threshold.
Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.

Revenue annual, last 8 years

Latest year +0.30% YoY

Margins

Gross margin: 18.26%
Operating margin: 2.39%
Net margin: -17.02%

Key ratios & quality

Enterprise value: 1.59B
Altman Z-Score: 1.37

Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.

Income statement

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	1.04B	1.02B	1.07B	930.70M	1.64B	2.03B	1.98B	1.99B
Gross profit	278.50M	290.00M	308.30M	183.20M	306.00M	355.80M	364.10M	362.90M
Selling & admin expenses	126.60M	138.80M	153.80M	185.70M	254.90M	263.90M	233.80M	228.70M
Research & development	15.20M	13.50M	13.80M	11.80M	18.80M	21.20M	23.00M	23.60M
Operating profit	136.70M	137.70M	140.70M	-14.30M	-21.10M	9.70M	44.40M	47.40M
Pretax profit	116.80M	96.90M	97.30M	-26.50M	-96.50M	-480.90M	-78.90M	-463.00M
Tax	10.70M	15.20M	18.40M	-28.20M	-27.60M	26.80M	-30.20M	-125.60M
Net profit	94.50M	85.80M	83.80M	88.90M	-6.60M	-309.50M	-48.70M	-337.40M
Basic EPS	3	3	3	3	0	-6	-1	-6
Diluted EPS	3.06	2.76	2.66	2.80	-0.18	-5.69	-0.90	-6.19

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
Revenue	484.80M	525.40M	513.70M	463.10M	479.60M	531.80M
Gross profit	72.60M	103.70M	99.40M	87.20M	84.90M	113.30M
Selling & admin expenses	63.30M	57.20M	53.70M	54.50M	54.80M	56.60M
Research & development	6.30M	6.70M	5.60M	5.00M	5.50M	4.90M
Operating profit	-12.40M	23.90M	24.10M	11.80M	8.60M	36.00M
Pretax profit	-450.20M	3.00M	-5.60M	-10.20M	-8.70M	6.80M
Tax	-24.70M	12.50M	-2.40M	-111.00M	3.00M	3.20M
Net profit	-425.50M	-9.50M	-3.20M	100.80M	-11.70M	3.60M
Basic EPS	-8	0	0	2	0	0
Diluted EPS	-7.82	-0.18	-0.06	1.80	-0.22	0.06

Balance sheet

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Total current assets	429.20M	427.50M	396.40M	594.60M	974.70M	712.50M	658.10M	638.60M
Cash & ST investments	93.80M	103.00M	54.70M	74.70M	101.10M	120.20M	94.30M	84.20M
Inventory	151.50M	161.40M	179.70M	259.50M	414.60M	352.90M	355.10M	329.10M
Total assets	1.47B	1.47B	1.58B	2.42B	3.67B	2.64B	2.45B	2.05B
Total current liabilities	143.50M	157.60M	166.90M	231.10M	466.20M	281.40M	274.50M	285.30M
Short-term debt	3.30M	1.90M	2.80M	10.50M	43.00M	14.10M	13.70M	13.70M
Long-term debt	618.80M	540.80M	590.50M	1.26B	1.66B	1.10B	1.09B	1.02B
Total liabilities	908,600,000.00	874,000,000.00	935,300,000.00	1,738,100,000.00	2,489,900,000.00	1,693,300,000.00	1,589,400,000.00	1,552,900,000.00
Total equity	557.90M	597.70M	649.60M	682.20M	1.18B	949.10M	858.50M	498.70M
Retained earnings	608.20M	638.40M	666.20M	696.40M	610.70M	235.00M	164.30M	-195.80M

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
Total current assets	686.20M	701.40M	672.40M	638.60M	664.90M	655.20M
Cash & ST investments	84.00M	95.60M	97.10M	84.20M	82.30M	66.30M
Inventory	346.00M	344.50M	330.30M	329.10M	334.70M	340.30M
Total assets	2.05B	2.08B	2.00B	2.05B	2.03B	1.99B
Total current liabilities	288.10M	295.50M	314.70M	285.30M	294.10M	331.30M
Short-term debt	13.60M	14.40M	13.80M	13.70M	12.20M	13.40M
Long-term debt	1.12B	1.09B	1.03B	1.02B	1.03B	970.10M
Total liabilities	1,624,100,000.00	1,660,100,000.00	1,604,100,000.00	1,552,900,000.00	1,562,400,000.00	1,520,000,000.00
Total equity	428.20M	416.60M	397.40M	498.70M	472.30M	470.70M
Retained earnings	-266.90M	-282.10M	-290.90M	-195.80M	-213.20M	-215.10M

Cash flow

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Operating cash flow	139.10M	160.30M	161.60M	58.00M	202.20M	106.60M	94.80M	133.80M
Depreciation & amortization	61.60M	57.70M	70.10M	67.10M	109.90M	147.80M	143.80M	141.00M
Free cash flow	109.40M	126.20M	128.30M	35.80M	154.00M	40.60M	39.80M	93.80M
Dividends paid	-53.20M	-54.40M	-55.00M	-55.30M	-72.20M	-55.30M	-21.60M	-22.30M
Stock buybacks / issuance	-3.00M	-900.00K	-1.00M	-3.40M	-6.90M	-10.60M	-800.00K	-1.40M
Ending cash balance	93.80M	103.00M	54.70M	74.70M	124.40M	120.20M	94.30M	89.80M

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
Operating cash flow	-15.90M	57.60M	72.80M	19.30M	1.00M	67.90M
Depreciation & amortization	35.30M	36.20M	34.80M	34.70M	34.80M	34.70M
Free cash flow	-29.80M	48.90M	66.70M	8.00M	-7.40M	60.40M
Dividends paid	-5.50M	-5.90M	-5.40M	-5.50M	-5.90M	-5.60M
Stock buybacks / issuance	-1.10M	-200.00K	-100.00K	0	-2.00M	-100.00K
Ending cash balance	93.80M	106.00M	102.90M	89.80M	87.30M	70.80M

Returns & efficiency

Line item	2018	2019	2020	2021	2022	2023	2024	2025
ROE %	17.11	14.75	13.26	13.19	-0.81	-29.15	-5.41	-49.82
ROA %	6.28	5.80	5.41	4.38	-0.25	-9.83	-1.92	-15.03
ROIC %	9.96	9.97	9.02	7.60	2.48	-10.34	-0.14	-15.93
5-year avg ROE %	15.22	14.78	13.69	12.93	11.48	2.25	-1.78	-14.40
EBIT margin %	13.92	13.00	11.90	8.28	2.85	-20.67	-0.21	-19.72
FCF / sales %	10.51	12.34	11.94	1.33	6.58	1.98	1.98	4.72
Current ratio	2.99	2.71	2.38	2.57	2.09	2.53	2.40	2.24
Quick ratio	1.82	1.64	1.25	1.40	0.64	1.16	1.01	0.99
Debt / assets	42.42	36.88	37.43	53.56	47.48	44.26	47.11	52.83
LT debt / equity	110.92	90.48	90.90	188.48	144.07	121.73	132.72	214.60
Interest coverage	5.14	3.68	4.19	2.59	0.72	-6.73	-0.06	-5.51
Revenue CAGR (3Y) %	10.87	6.79	3.04	-3.67	16.97	23.54	28.64	6.67
Net income CAGR (3Y) %	1.75	1.19	34.42	-2.02	--	--	--	--
FCF CAGR (3Y) %	-2.93	8.39	12.42	-31.09	6.86	-31.86	3.59	-15.23

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
ROE %	-66.87	-69.18	-68.33	-49.82	16.81	19.99
ROA %	-18.98	-19.41	-18.91	-15.03	3.70	4.36
ROIC %	-20.30	-20.96	-20.57	-15.93	7.42	8.54
5-year avg ROE %	--	--	--	--	--	--
EBIT margin %	-21.60	-20.96	-19.90	-19.72	2.49	2.71
FCF / sales %	1.76	2.34	4.40	4.72	5.86	6.42
Current ratio	2.38	2.37	2.14	2.24	2.26	1.98
Quick ratio	1.06	1.09	1.00	0.99	1.02	0.87
Debt / assets	57.81	55.93	54.77	52.83	54.01	51.99
LT debt / equity	273.89	275.32	272.37	214.60	230.09	217.02
Interest coverage	-5.72	-5.54	-5.35	-5.51	0.70	0.75
Revenue CAGR (3Y) %	--	--	--	--	--	--
Net income CAGR (3Y) %	--	--	--	--	--	--
FCF CAGR (3Y) %	--	--	--	--	--	--

✦ Quant Revenue Concentration how this is computed

Lead segment, long tail

Sustainable & Adhesive Solutions (SAS) is the largest reported line at 62.07% of revenue, across 2 reported segments.
Filtration & Advanced Materials (FAM) follows at 37.93%, so the top line still matters most but isn’t the whole story.

Revenue breakdown most recent period

Business

Sustainable & Adhesive Solutions (SAS)62.07%

Filtration & Advanced Materials (FAM)37.93%

Quote time 2026-10-09 19:30:05 · For reference only, not investment advice and not tailored to your situation.